Show simple item record

dc.contributor.authorLópez Montanero, Edith Elizabethspa
dc.contributor.authorMoscoso Solórzano, Grace Támaraspa
dc.contributor.authorAlvarado Villa, Geovannyspa
dc.contributor.authorMaldonado Guerrero, Bella Irmaspa
dc.contributor.authorFrías Toral, Evelyn Paolaspa
dc.contributor.authorJiménez Jiménez, Fanny Maribelspa
dc.contributor.authorIglesias Arreaga, Adriana Lissettespa
dc.date.accessioned2020-11-27 00:00:00
dc.date.accessioned2021-10-22T02:27:34Z
dc.date.available2020-11-27 00:00:00
dc.date.available2021-10-22T02:27:34Z
dc.date.issued2020-11-27
dc.identifier.issn2215-7840
dc.identifier.urihttps://hdl.handle.net/11227/13258
dc.format.mimetypeapplication/pdfspa
dc.language.isospaspa
dc.publisherUniversidad de Cartagenaspa
dc.relation.ispartofjournalRevista Ciencias Biomédicasspa
dc.rightsRevista Ciencias Biomédicas - 2020spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.sourcehttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/2983spa
dc.subjectCitomegalovirusspa
dc.subjectInfecciones por citomegalovirusspa
dc.subjectReceptores de trasplantesspa
dc.subjectReacción en cadena de la polimerasa.spa
dc.titlePrevalencia de citomegalovirus en niños sometidos a trasplante de médula ósea mediante reacción en cadena de la polimerasa en tiempo realspa
dc.typeArtículo de revistaspa
dc.title.translatedPrevalencia de citomegalovirus en niños sometidos a trasplante de médula ósea mediante reacción en cadena de la polimerasa en tiempo realeng
dc.identifier.doi10.32997/rcb-2015-2983
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa
dc.identifier.eissn2389-7252
dc.identifier.urlhttps://doi.org/10.32997/rcb-2015-2983
dc.relation.bitstreamhttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/2983/2516
dc.relation.citationeditionNúm. 1 , Año 2015spa
dc.relation.citationendpage59
dc.relation.citationissue1spa
dc.relation.citationstartpage53
dc.relation.citationvolume6spa
dc.relation.referencesJawezt E, Melnick A, Adelberg E. Microbiología médica, 25th ed. México: Mc Graw Hill, 2011. 449 págs.spa
dc.relation.referencesVillasís A, Mosqueda JL. Infecciones en trasplante de médula ósea. RevInvestClin. 2005; 57(2):381-6.spa
dc.relation.referencesGutiérrez J, Cruz L. Estudio de la seroprevalencia de la infección por citomegalovirus a través de la concentración sérica de IgG en un hospital de tercer nivel. RevMexPatolClin. 2008;55(4):175-86.spa
dc.relation.referencesBhadauria D, Sharma RK, Kaul A, Prasad N, Gupta A, Gupta A, et al. Cytomegalovirus disease in renal transplant recipients: a single-center experience. Indian J Microbiol. 2012 Sep;52(3):510-5.spa
dc.relation.referencesSagedal S, Hartmann A, Nordal, K, Osnes K, Leivestad T, Foss A, et al. Impact Of Early Cytomegalovirus Infection And Disease On Long - Term Recipient And Kidney Graft Survival. Kidney Int. 2004;66:329-37.spa
dc.relation.referencesBriganti E, Russ G, Graeme R, McNeil J, Atkins R, et al. Risk of renal allograft loss from recurrent glomerulonephritis. NEngl J Med. 2002;347(2):103-9.spa
dc.relation.referencesOnuigbo M, Haririan A, Ramos E, Klassen D, Wali R, Drachenberg C. Cytomegalovirus–Induced glomerular vasculopathy in renal allograft: A report of two cases. AJT. 2002;2:684-6.spa
dc.relation.referencesTomlinson L, Boriskin Y, McPhee I, et al. Acute citomegalovirus infection complicated by collapsing glomerulopathy. NDT. 2003;18:187-9.spa
dc.relation.referencesFishman J, Rubin R. Medical progress: infection in organ–transplant recipients. NEJM. 1998;338(24):1741-51spa
dc.relation.referencesMurray BM, Brentjens J, Amsterdam D, Holwill S, Rice P. Monitoring and diagnosis of cytomegalovirus infection in renal transplantation. J Am Soc Nephrol. 1997;8(9):1448–57.spa
dc.relation.referencesFishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med. 1998;338(24):1741–51.spa
dc.relation.referencesPouteil-Noble C, Ecochard R, Landrivon G, Donia-Maged, A, Tardy JC, Bosshard S,et al. Cytomegalovirus infection-an etiological factor for rejection? A prospective study in 242 renal transplant patients. Transplantation. 1993;55(4):851–7.spa
dc.relation.referencesSchroeder R, Michelon T ,Yo F , Bortolotto A, ämmerhirt E, Oliveira J, et al. Cytomegalovirus disease latent and active infection rates during the first trimester after kidney transplantation. Transplant Proc. 2004;36(4):896–8.spa
dc.relation.referencesMurray BM, Subramaniam S. Late cytomegalovirus infection after oral ganciclovir prophylaxis in renal transplant recipients. Transpl Infect Dis. 2004;6(1):3–9.spa
dc.relation.referencesLebranchu Y, Bridoux F, Büchler M, Meur Y, Etienne I, Toupance O, et al. Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy. Am J Trans. 2002;2:48–56.spa
dc.relation.referencesMourad G, Rostaing L, Legendre C, Garrigue V, Thervet E, Durand D. Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids. Transplantation. 2004;78(4):584–90.spa
dc.relation.referencesNemati E, Eizadi M, Moghani Lankarani M, Kardavani B, Khoddami HR. Cytomegalovirus disease after kidney transplantation: clues to accurate diagnosis. Transplant Proc. 2007;39:987–89.spa
dc.relation.referencesNakamura R, Battiwalla M, Solomon S, Follmann D, Chakrabarti S, Cortez K, et al. Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure. Biol Blood Marrow Transplant. 2004;10:49–57.spa
dc.relation.referencesNichols W, Corey L, Gooley T, Davis C, Boeckh M. High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection. J Infect Dis. 2002;185:273–82.spa
dc.relation.referencesBoeckh M, Nichols WG, Papanicolaou G, Rubin R, Wingard JR, Zaia J. Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies. Biol Blood Marrow Transplant. 2003;9:543–558.spa
dc.relation.referencesTey SK, Kennedy GA, Cromer D, et al. Clinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV® assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complications. PLoS One. 2013 Oct 11;8(10):e74744..spa
dc.relation.referencesXiao HW, Luo Y, Lai XY, Shi M, Tan M. Donor TLR9 gene tagSNPs influence susceptibility to aGVHD and CMV reactivation in the allo-HSCT setting without polymorphisms in the TLR4 and NOD2 genes. Bone Marrow Transplant. 2014;49:241-247.spa
dc.relation.referencesRasheed W, Ghavamzadeh A, Hamladji R, Ben T, Alseraihy A, Abdel F, et al Hematopoietic stem cell transplantation practice variation among centers in the Eastern Mediterranean Region (EMRO): Eastern Mediterranean Bone Marrow Transplantation (EMBMT) group survey. Hematol Oncol Stem Cell Ther. 2013;6(1):14-9. doi: 10.1016/j.hemonc.2013.04.001. Epub 2013 Apr 6.spa
dc.relation.referencesBarkam C, Kamal H, Dammann E, Diedrich H , Buchholz S, Eder M , et al. Improving safety of preemptive therapy with oral valganciclovir for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation. Bone Marrow Res. 2012;2012:874601. Epub 2012 Dec 3.spa
dc.relation.referencesPergam SA, Xie H, Sandhu R, Pollack M, Smith J, Ilieva , et al. Efficiency and risk factors for CMV transmission in seronegative hematopoietic stem cell recipients. Biol Blood Marrow Transplant. 2012 Sep;18(9):1391-400.spa
dc.relation.referencesYi ES, Kim YJ. Cytomegalovirus infection according to cell source after hematopoietic cell transplantation in pediatric patients.Yonsei Med J. 2012 Mar; 53(2):393-400.spa
dc.relation.referencesFarfán M, Torres J, Vergara A, Donoso G, Alba A, París C, et al. Comparación de las técnicas de reacción de polimerasa en cadena en tiempo real y antigenemia para la detección de citomegalovirus en sangre de niños sometidos a trasplantes. Rev Chil Infect. 2011; 28 (2): 113-17.spa
dc.relation.referencesGimeno C, Solano C, Latorre JC, Hernández JC, Clari MA, Remigia MJ, et. al. Quantification of DNA in plasma by an automated real-time PCR assay (Cytomegalovirus PCR Kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients. J Clin Microbiol. 2008; 46(10): 3311–18.spa
dc.relation.referencesPacheco M, Madero L. Oncología pediátrica. Psioncología. 2003; 0(1):107-116.spa
dc.relation.referencesDíaz A, de la Caridad M, Resik S. Infecciones por citomegalovirus. RevCubana MedGenIntegr. 1998;14(3):270-8.spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.localJournal articleeng


Files in this item

FilesSizeFormatView
Rev Cienc Biomed-2983.pdf23.45Kbapplication/pdfView/Open

This item appears in the following Collection(s)

Show simple item record

Revista Ciencias Biomédicas - 2020
Except where otherwise noted, this item's license is described as Revista Ciencias Biomédicas - 2020